Cargando…
Whole Tumor Antigen Vaccines: Where Are We?
With its vast amount of uncharacterized and characterized T cell epitopes available for activating CD4(+) T helper and CD8(+) cytotoxic lymphocytes simultaneously, whole tumor antigen represents an attractive alternative source of antigens as compared to tumor-derived peptides and full-length recomb...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494356/ https://www.ncbi.nlm.nih.gov/pubmed/26343191 http://dx.doi.org/10.3390/vaccines3020344 |